Status:
NOT_YET_RECRUITING
A Study in Non-Small Cell Lung Cancer
Lead Sponsor:
N-Power Medicine
Conditions:
Non Small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
A study to create control arms using current and future information in patients with lung cancer that has spread who have already received chemotherapy.
Eligibility Criteria
Inclusion
- 1\. \> 18 years of age at the time of informed consent 2. Pathologically confirmed NSCLC 3 .ECOG Performance of \>1 and fit for further systemic therapy on a NCCN approved regimen (within 4 weeks prior or 14 days after starting second line therapy) 4. Life expectancy of more than 3 months 5. Able to understand and sign informed consent \*see protocol for cohort specific inclusion criteria\*
Exclusion
- Unable to provide informed consent
- Actively on a clinical trial of an investigational agent
- Non protocol compliant baseline imaging scan (modality/coverage) prior to index date in patients included after the second or third line therapy has been initiated \*see protocol for cohort specific exclusion criteria\* -
Key Trial Info
Start Date :
December 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2029
Estimated Enrollment :
550 Patients enrolled
Trial Details
Trial ID
NCT07174388
Start Date
December 1 2025
End Date
April 1 2029
Last Update
November 28 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.